Evidence-based Chinese herbal medicine for cancer
Article Sidebar
Main Article Content
Abstract
Traditional Chinese medicine (TCM) has a long history of use both in the People’s Republic of China and in Chinese communities worldwide. Chinese herbal medicine, one of the most widely utilized aspects of TCM, has been employed to treat various diseases including cancer. This article compiles information on Chinese herbal medicine for the prevention and treatment of cancer, including the use of single herbs, herbal formulas, or in combination with Western medicine treatments. The data search was conducted using relevant scientific research papers over the past 10 years, including clinical trial, in-vivo and in-vitro studies, as well as the active compounds of the herbs used in treatment. The review found that the single herbs used to treat cancer include Huangqi (黄芪), Baihuasheshecao (白花蛇舌草), Danggui (当归), Renshen (人参), Sanqi (三七), Danshen (丹参), Banzhilian (半枝莲), etc., and herbal formulas that have been studied and reported in cancer patients include Yang Zheng Xiao Ji capsule (养正消积胶囊), Huangqin decoction (黄芩汤), Huajier granules (槐耳颗粒), Fufang Banmao capsule (复方斑蝥胶囊), Jinlong capsule (金龙胶囊). These findings suggest that Chinese herbal medicines, whether used alone, in compound formulas, or alongside conventional therapies, show promise in cancer prevention and treatment. They may contribute to reducing the adverse effects of modern treatments, enhancing immune function, and improving the quality of life in cancer patients.
Article Details
References
Dai ZQ, Liao X, Wielang LS, Hu J, Wang YY, Kim TH, et al. Cochrane systematic reviews on traditional Chinese medicine: what matters – the quantity or quality of evidence? Phytomedicine. 2022;98:153921.
So TH, Chan SK, Lee VHF, Chen BZ, Kong FM, Lao LX. Chinese medicine in cancer treatment – how is it practised in the East and the West? Clinical Oncology. 2019;31(8):578-88.
Yadav N, Deshmukh R, Mazumder R. A comprehensive review on the use of traditional Chinese medicine for cancer treatment. Pharmacol Res-Mod Chin Med. 2024;11:100423.
Hfocus. Department of Medical Services reveals that 140,000 new Thais are diagnosed with cancer each year, resulting in 83,000 deaths [internet]. 2024 [cited 2024 Nov 30]. Available from: https://www.hfocus.org/content/2024/02/29679 (in Thai)
Peng LJ, Zhang K, Li YJ, Chen LY, Gao HF, Chen H. Real-world evidence of traditional Chinese medicine (TCM) treatment on cancer: a literature-based review. Evidence-Based Complementary and Alternative Medicine. 2022;2022:7770380.
Li CL, Hsia TC, Li CH, Chen KJ, Yang YH, Yang ST. Adjunctive traditional Chinese medicine improves survival in patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a nationwide, population-based cohort study. Integr Cancer Ther. 2019;18:1534735419827079.
Gong YB, Xu ZY, Jin CJ, Deng HB, Wang ZQ, Zhou WD, et al. Treatment of advanced non-small-cell lung cancer with Qi-nourishing essence-replenishing Chinese herbal medicine combined with chemotherapy. Biol Proced Online. 2018;20:9.
Wang Q, Wang Q, Wang SF, Jiao LJ, Zhang RX, Zhong Y, et al. Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis. Curr Oncol. 2017;24(4):e269-76.
Wang LC, Chang YY, Lee IC, Kuo HC, Tsai MY. Systematic review and meta-analysis of Chinese herbal medicine as adjuvant treatment in advanced non-small cell lung cancer patients. Complementary Therapies in Medicine. 2020;52:102472.
Kuo YT, Liao HH, Chiang JH, Wu MY, Chen BC, Chang CM, et al. Complementary Chinese herbal medicine therapy improves survival of patients with pancreatic cancer in Taiwan: a nationwide population-based cohort study. Integrative Cancer Therapies. 2018;17(2):411-22.
Li KX, Xiao KM, Zhu SJ, Wang Y, Wang W. Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges. Front Pharmacol. 2022;13:889799.
Liao YH, Lin CC, Lao HC, Chiang JH, Lin JG, Li TC. Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients. Liver International. 2015;35(12):2595-602.
Chao TH, Fu PK, Chang CH, Chang SN, Mao FC, Lin CH. Prescription patterns of Chinese herbal products for post-surgery colon cancer patients in Taiwan. J Ethnopharmacol. 2014;155(1):702-8.
Hung KF, Hsu CP, Chiang JH, Lin HJ, Kuo YT, Sun MF, et al. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: a nationwide retrospective matched-cohort study. J Ethnopharmacol. 2017;199:168-74.
Feng RQ, Li DH, Liu XK, Zhao XH, Wen QE, Yang Y. Traditional Chinese medicine for breast cancer: a review. Breast Cancer. 2023;15:747-59.
Lin YS, Shen YC, Wu CY, Tsai YY, Yang YH, Lin YY, et al. Danshen improves survival of patients with breast cancer and dihydroisotanshinone I induces ferroptosis and apoptosis of breast cancer cells. Front Pharmacol. 2019;10:01226.
Tsai YT, Lai JN, Wu CT. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study. J Ethnopharmacol. 2014;155(2):1256-62.
Li S, So TH, Tang GY, Tan HY, Wang N, Ng BFL, et al. Chinese herbal medicine for reducing chemotherapy-associated side-effects in breast cancer patients: a systematic review and meta-analysis. Front Oncol. 2020;10:599073.
Zhu LB, Li LR, Li YS, Ji W, Qi W. Chinese herbal medicine as an adjunctive therapy for breast cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016;2016:9469276.
Lee YC, Chen YH, Huang YC, Lee YF, Tsai MY. Effectiveness of combined treatment with traditional Chinese medicine and Western medicine on the prognosis of patients with breast cancer. J Altern Complement Med. 2020;26(9):835-42.
Lin HC, Lin CL, Huang WY, Shangkuan WC, Kang BH, Chu YH, et al. The use of adjunctive traditional Chinese medicine therapy and survival outcome in patients with head and neck cancer: a nationwide population-based cohort study. QJM: An International Journal of Medicine. 2015;108(12):959-65.
Wang RY, Sun QH, Wang F, Liu Y, Li X, Chen TH, et al. Efficacy and safety of Chinese herbal medicine on ovarian cancer after reduction surgery and adjuvant chemotherapy: a systematic review and meta-analysis. Front Oncol. 2019;9:730.
Wang C, Lin KYH, Wu MY, Lin CL, Lin JG, Chang CYY, et al. Adjunctive Chinese herbal medicine treatment is associated with an improved survival rate in patients with cervical cancer in Taiwan: a matched cohort study. Integr Cancer Ther. 2021;20:15347354211061752.
Nie J, Zhao CL, Deng L, Chen J, Yu B, Wu XL, et al. Efficacy of traditional Chinese medicine in treating cancer (Review). Biomed Rep. 2016;4(1):3-14.
Kong MY, Li LY, Lou YM, Chi HY, Wu JJ. Chinese herbal medicines for prevention and treatment of colorectal cancer: from molecular mechanisms to potential clinical applications. J Integr Med. 2020;18(5):369-84.
Xie RF, Song ZY, Xushao LY, Huang JG, Zhao T, Yang Z. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking. Medicine (Baltimore). 2022;101(52):32555.
Hue C. Chinese and Western herbal medicine: a guide to potential risks and drug interactions [Internet]. 2004 [cited 2025 May 30]. Available from: https://ethnomed.org/resource/chinese-and-western-herbal-medicine-a-guide-to-potential-risks-and-drug-interactions/
